[Image source=Yonhap News]

[Image source=Yonhap News]

View original image

[Asia Economy Reporter Seo So-jung] Amid disruptions in vaccine supply due to export restrictions on COVID-19 vaccines from Europe and India, the government has decided to fully activate the Pan-Government Vaccine Procurement Task Force (TF) to respond with all-out efforts.


The government announced on the 1st that it will officially launch the 'Pan-Government Vaccine Procurement TF' through a joint effort of related ministries to ensure the smooth progress of COVID-19 vaccination.


The 'Pan-Government Vaccine Procurement TF' is led by the Minister of Health and Welfare and consists of five sectors: overall vaccine procurement (Ministry of Health and Welfare), practical support (Korea Disease Control and Prevention Agency), rapid approval and release authorization (Ministry of Food and Drug Safety), raw material supply support (Ministry of Trade, Industry and Energy), and international cooperation support (Ministry of Foreign Affairs). Heads and vice ministers of related ministries and agencies participate.


To monitor vaccine supply status and enable rapid response, a practical support team (with participation from director-level officials of related ministries) will be organized under the leadership of the Director of the Health and Medical Policy Office of the Ministry of Health and Welfare.


Additionally, to ensure the solid operation of the Pan-Government Vaccine Procurement TF, a 'Vaccine Procurement Secretariat' will be established within the Central Disaster and Safety Countermeasures Headquarters.



Kwon Deok-cheol, TF leader (Minister of Health and Welfare), stated, "We plan to mobilize all government-level capabilities to ensure stable and continuous supply of COVID-19 vaccines," adding, "We ask for active participation in vaccination to overcome COVID-19 and quickly restore our precious daily lives."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing